Pro-repair properties of a human embryonic stem cell-derived astrocyte cell therapy in demyelinating disorders
Lihi Sofer Stepanov, Nina Fainstein, Marva Lachish, Tal Ganz, Yoel Shor, Gal Lebiush Shalom, Shir Klein-Lavi, Michal Izrael, Debora Steiner, Benjamin E. Reubinoff, Michel Revel, Tamir Ben-Hur · 2026
Read Pro-repair properties of a human embryonic stem cell-derived astrocyte cell therapy in demyelinating disorders by Lihi Sofer Stepanov, Nina Fainstein, Marva Lachish, Tal Ganz, Yoel Shor, Gal Lebiush Shalom, Shir Klein-Lavi, Michal Izrael, Debora Steiner, Benjamin E. Reubinoff, Michel Revel, Tamir Ben-Hur (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13385419.txt.
Description
Lihi Sofer Stepanov and a large team test a stem cell derived astrocyte therapy for myelin repair in 2026 work. In diseases like multiple sclerosis, repair fails because debris lingers and precursor cells stall before maturing. The therapy, AstroRx, comes from human embryonic stem cells and is made to clinical grade.
In dish studies, the astrocytes helped scavenger cells clear myelin debris and guided precursors toward maturity. In a rat-like mouse model of myelin injury, delivery into the brain's fluid spaces boosted debris clearing and new sheath cell growth near lesions. The team presents AstroRx as a ready-made, multi-action repair candidate.
Catalog record
| CREATOR | Lihi Sofer Stepanov, Nina Fainstein, Marva Lachish, Tal Ganz, Yoel Shor, Gal Lebiush Shalom, Shir Klein-Lavi, Michal Izrael, Debora Steiner, Benjamin E. Reubinoff, Michel Revel, Tamir Ben-Hur |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60103 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |